IP Library Granted Patent US 9,868,977
Granted Patent B2
US 9,868,977 · App. 15/269,032 · Granted Jan 16, 2018

Red-shifted luciferins and methods of using same

Inventor: Carolyn Woodroofe Hitko (Grover Beach, CA)
Assignee: PROMEGA CORPORATION
C12Q1/66A61K49/0021C07D277/84C07D417/04C07D417/14C07D513/04C07D513/14C07D513/22C12Q1/44C12Y113/12007C12Y301/01G01N2333/90241G01N2333/918
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,868,977
App. No.
15/269,032
Granted
Jan 16, 2018
Kind
B2
Abstract

Novel red-shifted luciferin derivatives and uses of those compounds are provided.

Claims (64)

1. A compound according to Formula (XI):

wherein

X is CN or

Y is OR; and

R is

2. A compound according to Formula (XII):

wherein

X is CN or

Y is OR;

R is

A is OH or NHAc; and

each R 5 is independently H, a monosaccharide or a polyethylene glycol moiety of up to 40 units.

3. A compound according to Formula (XIII):

wherein

X is CN or

Y is NHR;

R is

R 7 is an amino acid side chain; and

R 6 is H, a nitrogen protecting group, or a chain of up to 35 amino acids.

4. A compound according to Formula (XV):

wherein

X is CN or

Y is OR; and

R is C 1-10 alkyl, substituted C 1-10 alkylaryl, substituted aryl, aralkyl or substituted aralkyl.

5. A compound according to Formula (XVI):

wherein

X is —CH(OR 10 ) 2 ;

R 10 is C 1-4 alkyl, substituted C 1-4 alkyl, benzyl or substituted benzyl;

Y is OR 1 or NR 1 R 2 ; and

R 1 is H, C 1-10 alkyl or substituted C 1-10 alkyl;

R 2 is H, C 1-10 alkyl or substituted C 1-10 alkyl; or

R 1 and R 2 together form a 4 to 8 membered ring.

6. A compound according to Formula (XVII):

wherein

R 8 is CH 2 OH, C(O)R 10 or —C(O)ZR 9 ;

Z is O or NH;

R 9 is C 1-7 alkyl or substituted C 1-7 alkyl;

R 10 is a peptide;

Y is OR 1 or NR 1 R 2 ; and

R 1 is H, C 1-10 alkyl or substituted C 1-10 alkyl;

R 2 is H, C 1-10 alkyl or substituted C 1-10 alkyl; or

R 1 and R 2 together form a 4 to 8 membered ring.

7. A compound according to Formula (XVIII):

wherein

X is CN or

Y is OR;

R is

each R 11 is independently H, C 1-6 alkyl, substituted C 1-6 alkyl, CF 3 , halogen, NO 2 , or CO 2 R 12 provided that at least one of R 11 is NO 2 ;

R 12 is H, C 1-6 alkyl or substituted C 1-6 alkyl; and

m is 1 or 2.

8. A compound according to Formula (XX):

wherein

X is CN or

Y is L-R;

L is a linker; and

R is a boronic acid or borate ester.

9. A kit comprising a compound according to claim 1 .

10. The kit of claim 9 further comprising a luciferase.

11. The kit of claim 9 , further comprising a buffer reagent.

12. A compound according to Formula (XV):

wherein

X is

Y is H or OR; and

R is C 1-10 alkyl, substituted C 1-10 alkylaryl, substituted aryl, aralkyl or substituted aralkyl.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2017
From: HITKO, CAROLYN WOODROOFE
To: PROMEGA CORPORATION
Reel/Frame 040987/0691 →
Continuity (3)
Continuation 14200563 · Mar 7, 2014
Provisional Application 61777208 · Mar 12, 2013
Related Publication 20170002396A1 · Jan 5, 2017